S. 1720: Patent Transparency and Improvements Act of 2013

Before you vote › Federal bills

S. 1720: Patent Transparency and Improvements Act of 2013

113th Congress · introduced 2013-11-18 · Commerce · Latest: Committee on the Judiciary. Hearings held.

federal

Save to my notebook What does this mean? Print

Official title

Patent Transparency and Improvements Act of 2013

Plain summary

Patent Transparency and Improvements Act of 2013 - Directs a court to require a patentee who has filed a civil action for patent infringement to disclose to the court and to all adverse parties any persons, associations, corporations (including parent corporations), or other entities known by the patentee to have: (1) a financial interest in the subject matter in controversy or in a party to the proceeding, or (2) any other interest that could be substantially affected by the outcome of the proceeding. Requires any assignment of all substantial rights in an issued patent that results in a change to the ultimate parent entity to be recorded in the U.S. Patent and Trademark Office (USPTO) within three months of the assignment. Prohibits a party asserting infringement from recovering increased damages or attorney's fees with respect to infringing activities taking place during any period of noncompliance in which the ultimate parent entity of an assignee has not been disclosed to the USPTO. Requires courts, if such an assignment has not been disclosed, to award a prevailing accused infringer reasonable attorney's fees and expenses incurred in discovering any previously undisclosed ultimate parent entities. Directs courts to grant a motion to stay an action against a customer accused of infringing a patent based on a product or process under specified conditions when: (1) the manufacturer is a party to the action or to a separate action involving the same patent relating to the same product or process, and (2) the customer agrees to be bound under principles of collateral estoppel by any common issues finally decided as to such manufacturer. Requires the Federal Trade Commission (FTC) to: (1) exercise enforcement authority with respect to bad-faith demand letters (widespread written communications with false or misleading information stating that the intended recipients or affiliated persons are infringing or have infringed a patent and bear liability or owe compensation), and (2) treat such letters as unfair or deceptive acts or practices. Directs the USPTO to notify the public on its website when a patent case is brought in federal court. Limits the grounds for invalidity of a patent claim that a post-grant review petitioner is prohibited, by estoppel, from asserting in subsequent civil actions (or certain U.S. International Trade Commission [USITC] proceedings) to only those grounds that the petitioner actually raised during post-grant review. (Currently, the petitioner is estopped from asserting claims that the petitioner raised or could have raised during such review.) Requires claims of patent in post-grant and inter partes review proceedings to be construed in the same manner as a court would construe such claims in a civil action to invalidate the patent, including by interpreting the claim in accordance with its ordinary and customary meaning, as well as the prosecution history pertaining to the patent. (Currently, the USPTO construes claims by considering the broadest reasonable interpretation.) Makes U.S. bankruptcy law applicable in cross-border bankruptcy cases in which the debtor is a licensor of intellectual property rights and a foreign proceeding is pending in the country where the debtor has the center of its main interests, thereby permitting a licensee to retain its right in such intellectual property if the trustee rejects the underlying executory contract. Expands the definition of "intellectual property" as it applies to the federal bankruptcy code to include trademarks, service marks, or trade names (thereby providing for trademark licenses to be retained instead of voided in bankruptcy). Prohibits trustees, if a trademark licensee elects to retain such rights, from being relieved of a contractual obligation to monitor and control the quality of a licensed product or service. Codifies judicial doctrine relating to the consideration of prior art in cases of double patenting for the purpose of determining the nonobviousness of a second patent's claimed invention, thereby specifying that such doctrine continues to apply to the first-inventor-to-file patent system under the Leahy-Smith America Invents Act.

Congressional Research Service summary (Introduced in Senate), quoted unchanged (nonpartisan). Read the source.

What a vote does

PSI Sci description of the legislative step (not an opinion).

The strongest published arguments

Alternatives

Needs sources: no published alternatives yet (for example a different bill, a law instead of an amendment, or keeping current law). We only show items backed by a published source. Suggest one.

How did my representative vote? · This bill's floor votes

Officials and money

Sponsor: Sen. Leahy, Patrick J. [D-VT] · 3 cosponsors

Cost estimate: No cost estimate published yet.

Cosponsors on this site

Mike Lee (R-UT), Sheldon Whitehouse (D-RI), Amy Klobuchar (D-MN)

No linked floor roll calls in our collected records yet. This does not mean the bill has never had a vote. Check the official bill history.

Sources

• Congressional Research Service summary (Introduced in Senate)
• Congress.gov
• Data: GovInfo BILLSTATUS bulk data (Library of Congress), BILLSTATUS-113s1720.xml <https://www.govinfo.gov/bulkdata/BILLSTATUS/113/s>

Record fed-us-cong113-s1720 · catalog fed-us-congress-bills-cong113 · updated 2026-11-15 by psicol fed-bills-cong113